ライフサイエンスコーパス: stem cell-derived

1 have emerged as two distinct approaches for stem cell-derived 3D tissue preparation.

2 arkers for potency prediction of mesenchymal stem cell-derived and pluripotent stem cell-derived mult

3 NA profiling during differentiation of human stem cell-derived and primary murine oligodendrocytes in

4 phB1-ephrin-B1 pathway is disrupted in human stem cell derived astrocyte and mouse models of amyotrop

5 ber of recent studies have demonstrated that stem cell-derived astrocytes exhibit a range of properti

6 rain and highlight the extent to which human stem cell-derived astrocytes have demonstrated functiona

7 ADAR1 by short hairpin RNAs in human neural stem cell-derived astrocytes, human primary astrocytes,

8 eplacement therapies (such as human islet or stem cell-derived beta cell transplantation) without imm

9 To determine whether stem cell-derived beta cells recapitulate molecular-phys

10 this review, we will discuss the utility of stem cell-derived beta cells to investigate the mechanis

11 e scalable in vitro production of functional stem cell-derived beta-cells (SC-beta cells).

12 re relevant for generation of transplantable stem cell-derived beta-cells.

13 These stem-cell-derived beta cells (SC-beta) express markers f

14 PS is able to keep human induced pluripotent stem cell derived cardiac tissue viable and functional o

15 ells to generate a human-induced pluripotent stem cell-derived cardiac muscle patch (hCMP), which was

16 or functional screening in human pluripotent stem cell-derived cardiac organoids (hCOs).

17 tion properties of human-induced pluripotent stem cell-derived cardiac tissues.

18 the maturation of human-induced pluripotent stem cell-derived cardiac tissues.

19 thin maturing, unlabeled induced pluripotent stem cell-derived cardiomyocyte cultures.

20 Mapping of induced pluripotent stem cell-derived cardiomyocyte networks and in vivo inv

21 Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) offer a nov

22 The immature phenotype of human pluripotent stem cell derived cardiomyocytes (hPSC-CMs) constrains t

23 Induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) provide a hu

24 Human pluripotent stem cell-derived cardiomyocytes (CMs) are a promising t

25 Human embryonic stem cell-derived cardiomyocytes (hESC-CMs) and HepG2 ce

26 atures in 1-year (y) matured human embryonic stem cell-derived cardiomyocytes (hESC-CMs) are similar

27 Human embryonic stem cell-derived cardiomyocytes (hESC-CMs, >90% troponi

28 RATIONALE: Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) are increasi

29 Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are a power

30 t patient-specific human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) can recapit

31 y examined whether human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) could be us

32 e increased use of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) for drug de

33 rated a library of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) from patien

34 drug effects with human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) provide new

35 beat amplitude in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), but D-ala,

36 Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), fibroblast

37 In human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), Tbx20 enha

38 te postnatal maturation in human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs), limiting th

39 makers in animal models, induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have not bee

40 dies investigating human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have propose

41 ered cardiac tissues made of mouse embryonic stem cell-derived cardiomyocytes (mESC-CMs).

42 Pluripotent stem cell-derived cardiomyocytes also prove to be mechan

43 that suppression of PRRX1 in human embryonic stem cell-derived cardiomyocytes and embryonic zebrafish

44 and engraftment of human induced pluripotent stem cell-derived cardiomyocytes and enable the bioengin

45 e EHM from embryonic and induced pluripotent stem cell-derived cardiomyocytes and fibroblasts with or

46 tilide exposure in human-induced pluripotent stem cell-derived cardiomyocytes and in Chinese hamster

47 remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation

48 l-targeted drugs, and phenotyping and use of stem cell-derived cardiomyocytes and other biologics all

49 We constructed EHMs from human embryonic stem cell-derived cardiomyocytes and released them for t

50 ercially available human induced pluripotent stem cell-derived cardiomyocytes are a powerful model fo

51 Although induced pluripotent stem cell-derived cardiomyocytes are distinct from adult

52 ecially patient specific induced pluripotent stem cell-derived cardiomyocytes are well established as

53 he use of isogenic human induced pluripotent stem cell-derived cardiomyocytes as a physiologically re

54 Additionally, in human embryonic stem cell-derived cardiomyocytes challenged with TNFalph

55 The therapeutic success of human stem cell-derived cardiomyocytes critically depends on t

56 The patient-derived induced pluripotent stem cell-derived cardiomyocytes display (1) significant

57 functional properties of induced pluripotent stem cell-derived cardiomyocytes from a patient with D13

58 functional properties of induced pluripotent stem cell-derived cardiomyocytes from a patient with D13

59 wever, recent studies have demonstrated that stem cell-derived cardiomyocytes generated from patients

60 r, to date, electrophysiological analyses of stem cell-derived cardiomyocytes has largely been limite

61 Induced pluripotent stem cell-derived cardiomyocytes have been used to study

62 with patch-clamp studies, on human embryonic stem cell-derived cardiomyocytes hESC-CMs.

63 ological maturation of the human pluripotent stem cell-derived cardiomyocytes in our system recapitul

64 e show that electrical conditioning of human stem cell-derived cardiomyocytes in three-dimensional cu

65 cardiomyocytes and human induced pluripotent stem cell-derived cardiomyocytes in vitro and in vivo in

66 zebrafish hearts in vivo as well as in human stem cell-derived cardiomyocytes in vitro.

67 Stem cell-derived cardiomyocytes mutated to carry the ef

68 Human-induced pluripotent stem cell-derived cardiomyocytes provide a cell source f

69 Stem cell-derived cardiomyocytes provide a promising too

70 As human pluripotent stem cell-derived cardiomyocytes remain functionally fet

71 cing structural and functional maturation of stem cell-derived cardiomyocytes remains a key challenge

72 Induced pluripotent stem cell-derived cardiomyocytes resemble, but are not i

73 Using induced pluripotent stem cell-derived cardiomyocytes to predict patient-spec

74 epair from embryonic and induced pluripotent stem cell-derived cardiomyocytes under defined, serum-fr

75 s) were generated by casting human embryonic stem cell-derived cardiomyocytes with collagen in prefor

76 d a functional rescue in induced pluripotent stem cell-derived cardiomyocytes with D130G-CALM2, as sh

77 entiated cardiomyocytes (induced pluripotent stem cell-derived cardiomyocytes) now provide a novel mo

78 e report that, in mouse primary or embryonic stem cell-derived cardiomyocytes, increased calcium leve

79 proximately 50 000 human-induced pluripotent stem cell-derived cardiomyocytes, smooth muscle cells, a

80 Using human induced pluripotent stem cell-derived cardiomyocytes, we not only confirmed

81 nd evaluate the maturation state of cultured stem cell-derived cardiomyocytes.

82 art scaffolds with human induced pluripotent stem cell-derived cardiomyocytes.

83 cardiac matrix and human induced pluripotent stem cell-derived cardiomyocytes.

84 IFN immunity using human induced pluripotent stem cell-derived cardiomyocytes.

85 such as isolated adult and human pluripotent stem cell-derived cardiomyocytes; (2) 2-dimensional in v

86 ayers or small clusters of human pluripotent stem cell-derived cardiomyocytes; (3) 3-dimensional mult

87 nd also overexpressed in induced pluripotent stem cells derived cardiomyocytes (iPSCs-CM).

88 ed cytotoxicity in human induced pluripotent stem cells-derived cardiomyocytes (iPS-CMs).

89 Studies of human embryonic-stem-cell-derived cardiomyocytes (hESC-CMs) in small-ani

90 opmental ages of human and mouse pluripotent stem-cell-derived cardiomyocytes and characterized linea

91 diting of the rs2595104 risk allele in human stem-cell-derived cardiomyocytes resulted in diminished

92 en seen as one of the first applications for stem cell-derived cells because of the loss of only a si

93 Integration of stem cell-derived cells into native cellular environment

94 factor binding data from purified embryonic stem cell-derived cells representing six sequential stag

95 ghput screening in human induced pluripotent stem cell-derived cells with the intent of identifying n

96 ads to microcephaly, we used human embryonic stem cell-derived cerebral organoids to recapitulate ear

97 eloping mouse and ferret cortex and in human stem cell-derived cerebral organoids, highlighting multi

98 fferentiation and followed the maturation of stem cell-derived clones using sparse lineage tracing in

99 Human and mouse pluripotent stem cell-derived CMs (PSC-CMs) were transduced with the

100 ular myocytes, and human induced pluripotent stem cell-derived CMs, decreasing expression of hypertro

101 loss-of-function approaches in an embryonic stem cell-derived cortical differentiation model, we rep

102 tent chemical screen using human pluripotent stem cell-derived cortical neural progenitor cells (hNPC

103 ranscriptional responses in developing human stem cell-derived cortical neurons with those induced in

104 ions of genes that are enriched in embryonic stem cell-derived CPCs.

105 SCs than mature neurons in a human embryonic stem cell-derived culture containing a mixture of cell t

106 mesencephalic and human induced pluripotent stem cells-derived DA neurons.

107 mesencephalic and human induced pluripotent stem cells-derived DA neurons.

108 onoclonal antibodies against human embryonic stem cell-derived definitive endoderm with the goal of i

109 and that this molecule is inducible in human stem cell-derived dopamine (DA) neurons.

110 Transplantation of human pluripotent stem cell-derived dopaminergic neurons is a promising ap

111 derived fibroblasts, and induced pluripotent stem cell-derived dopaminergic neurons.

112 Here, a live stem cell derived embryoid body (EB) based cardiac cell

113 ing in zebrafish embryos and mouse embryonic stem cell-derived embryoid bodies substantially decrease

114 ndothelial cells (hESC-EC), as well as other stem cell derived endothelial cells, have a range of app

115 Human embryonic stem cell-derived endothelial cells (hESC-EC), as well a

116 Human embryonic stem cell-derived endothelial cells (hESC-ECs) were susp

117 Human induced pluripotent stem cell-derived endothelial cells (hiPSC-ECs) adopted

118 e, we used comparison of induced pluripotent stem cell-derived endothelial cells (iPSC-ECs) from thre

119 our study indicates that induced pluripotent stem cell-derived endothelial cells are useful surrogate

120 CRISPR-edited stem cell-derived endothelial cells demonstrate rs934937

121 e pulmonary arterial and induced pluripotent stem cell-derived endothelial cells from patients with i

122 e a method for introducing human pluripotent stem cell-derived enteric neural crest cells into develo

123 Human intestinal stem cell-derived enteroid monolayers co-cultured with h

124 Here, we used stem cell-derived enteroids from human small intestines

125 le macrophages, dendritic cells, B cells and stem-cell-derived enteroids can all support infection of

126 We have designated the stem cell-derived epithelia harboring hair cells, suppor

127 Primary human airway basal stem cell-derived epithelial cultures and micro-optical

128 stinal matrix with human induced pluripotent stem cell-derived epithelium and human endothelium, and

129 g functional properties of human pluripotent stem cell-derived excitatory cortical neurons, in the co

130 fibroblasts, demonstrating a direct role of stem cell-derived exosomes on mouse endothelium at the c

131 ts of mesenchymal stem cells and mesenchymal stem cell-derived factors in organotypic retinal explant

132 luding in vitro cultured induced pluripotent stem cell-derived forebrain neurons and in vivo neurons

133 ere downregulated in the induced pluripotent stem cell-derived forebrain neurons from the subjects ca

134 n endocrine-active human-induced pluripotent stem cell-derived foregut epithelial cells and hypothala

135 ifferentiated from human-induced pluripotent stem cells derived from 4 individuals with schizophrenia

136 In vitro cultured neural stem cells derived from Cic conditional knockout mice by

137 ferentiated neurons from induced pluripotent stem cells derived from fibroblasts of controls and pati

138 of human bone marrow stem cells (BMSC) with stem cells derived from human dental pulp (DPSC), apical

139 in medium spiny-like neurons generated from stem cells derived from individuals with HD, indicating

140 ed decay rates in differentiated trophoblast stem cells derived from KO blastocysts.

141 lls (GPCs) produced from induced pluripotent stem cells derived from patients with childhood-onset SC

142 ellular phenotypes) with induced pluripotent stem cells derived from patients.

143 ells differentiated from induced pluripotent stem cells derived from schizophrenia patients show high

144 KBM7 and HAP1), as well as haploid embryonic stem cells derived from several organisms.

145 In this proof-of-concept study, using stem cells derived from skeletal muscle of a DMD patient

146 Mouse embryonic stem cells derived from the epiblast contribute to the s

147 erconnectivity, based on induced pluripotent stem cells derived from the respective individuals.

148 nd are well conserved in induced pluripotent stem cells derived from the twins' fibroblasts.

149 This enabled us to discover that neural stem cells, derived from the murine spinal cord and orga

150 erse range of tissue-derived and pluripotent stem cell-derived gastrointestinal (GI) tissues in vitro

151 Moreover, these stem-cell-derived hair cells exhibit functional properti

152 larly discuss the importance of benchmarking stem cell-derived hepatocyte-like cells to their termina

153 tion of 0.94 between TC50 values obtained in stem cell-derived hepatocytes and primary cells, compare

154 graftment and in vivo HCV infection of human stem cell-derived hepatocytes and provides a model to st

155 Finally, stem cell-derived hepatocytes demonstrate all toxicologi

156 oughput using cell lines, primary cells, and stem cell-derived hepatocytes.

157 more-efficient differentiation protocols for stem-cell-derived hepatocytes and broaden our understand

158 VZV-infected fibroblasts and human embryonic stem cell-derived (hESC) neurons.

159 decreases PDE11A mRNA in induced pluripotent stem cell-derived hippocampal neurons originating from l

160 acement of beta cells with human pluripotent stem cell-derived (hPSC-derived) cells, which are curren

161 ming properties of human induced pluripotent stem cell-derived HSPCs (hiPS-HSPCs).

162 esulted from in vitro modeling of primary or stem cell-derived human CNS cells and cell lines.

163 oned media of N2a cells, induced pluripotent stem cell-derived human cortical neurons, and primary ra

164 ned medium of N2a cells, induced pluripotent stem cell-derived human cortical neurons, and primary ra

165 Finally, exposure of stem cell-derived human embryoid bodies to hsa-miR-1294

166 We exposed stem cell-derived human embryoid bodies to the microRNA

167 Inducible pluripotent stem cell-derived human endothelial cells carrying the r

168 Induced pluripotent stem cell-derived human hepatocyte-like cells (iHeps) co

169 Stem cell-derived human hypothalamic neurons share chara

170 Pluripotent stem cell-derived human primordial germ cell-like cells

171 analysis of selected genes was performed in stem cell-derived human retinal cells.

172 ate that the epithelium of human pluripotent stem-cell-derived human intestinal organoids is globally

173 Moreover, ZIKV productively infects stem-cell-derived human neural crest cells and periphera

174 deactivated following Lhx3 downregulation in stem-cell-derived hypaxial motor neurons.

175 Thus, we posit that stem cell-derived interneuron transplants may be an effe

176 These data suggest that the stem cell-derived interneuron transplants may represent

177 stinal matrix with human induced pluripotent stem cell-derived intestinal epithelium and human endoth

178 ines as well as in induced human pluripotent stem cell-derived intestinal organoids, and confirm in v

179 Using human embryonic stem cell-derived intestinal organoids, we demonstrate t

180 om studies of tissue-derived and pluripotent stem cell-derived intestinal, gastric, esophageal, liver

181 Induced pluripotent stem cell-derived (iPS-derived) neural precursor cells m

182 e reduced in PWS patient induced pluripotent stem cell-derived (iPSC-derived) neurons.

183 of nearby genes in human induced pluripotent stem cell-derived (iPSC-derived) neurons.

184 s also observed in human-induced pluripotent stem cell-derived JNCL neural progenitor cells.

185 Human-pluripotent-stem-cell-derived kidney cells (hPSC-KCs) have important

186 well as the contractile development of human stem cell-derived laminar cardiac tissues over four week

187 nalyze the transcriptomes of human embryonic stem cell-derived lineage-specific progenitors by single

188 We demonstrate that pluripotent stem cell-derived LPCs choose hepatic fate when cultured

189 e therapeutic potential of human pluripotent stem cell-derived lymphoid cells generated to date remai

190 nduced SM differentiation of human embryonic stem cell-derived mesenchymal cells.

191 These in vitro pluripotent stem cell-derived microglia-like cells (termed pMGLs) fa

192 poreal CO2 removal technique and mesenchymal stem cell-derived microparticles, have also been studied

193 SC frequency, and impaired reconstitution of stem cell-derived mixed-lineage leukemia (MLL) AML, whic

194 nscriptional analysis on immature and mature stem cell-derived MKs exposed to physiological shear.

195 are deregulated in human-induced pluripotent stem cell-derived MNs carrying the FUS(P525L) mutation a

196 ic ALS (sALS) astrocytes and human embryonic stem-cell-derived MNs.

197 h endogenous spinal motoneurons or embryonic stem cell-derived motoneurons (ESCMNs).

198 ed lymphoblastoid cells, induced pluripotent stem cell-derived motor neurons and post-mortem brain sa

199 function in vivo and in vitro, including in stem cell-derived motor neurons from ALS patients bearin

200 We generated murine embryonic stem cell-derived motor neurons that express the light-s

201 In human stem cell-derived motor neurons, the RNA profile associa

202 -derived fibroblasts and induced pluripotent stem cell-derived motor neurons.

203 blastoma cells and human induced pluripotent stem cell-derived motor neurons.

204 Finally, interrogation of stem-cell-derived motor neurons produced from ALS patien

205 with those induced in developing primary- or stem cell-derived mouse cortical neurons.

206 elevance of the method by imaging lipid-rich stem-cell-derived mouse adipocytes as well as differenti

207 uld enhance expansion and differentiation of stem cell-derived MPCs.

208 esenchymal stem cell-derived and pluripotent stem cell-derived multicellular organoids.

209 to recover and do not elicit cKit(+) cardiac stem cell-derived myocyte regeneration.

210 We demonstrated that weaker stem cell-derived myocytes coupled with stronger myocyte

211 s from data generated in induced-pluripotent-stem-cell-derived myocytes from familial cardiomyopathy

212 ty and tolerability of human parthenogenetic stem cell derived neural stem cells ISC-hpNSC for treati

213 ns from 100 ng of RNA from human pluripotent stem cell-derived neural cells.

214 nt of synchronized maturation of pluripotent stem cell-derived neural progenitor cells generates neur

215 synchronize the neurogenesis of pluripotent stem cell-derived neural progenitors and accelerate thei

216 deling ZIKV exposure using human pluripotent stem cell-derived neural progenitors and brain organoids

217 Here, embryonic stem cell-derived neural progenitors were found to form

218 genitor cells in vivo and on human embryonic stem cell-derived neural progenitors.

219 Induced pluripotent stem cell-derived neural stem cells (iNSCs) have signifi

220 ethod to quantify network formation in human stem cell derived neurons and show for the first time, c

221 jury model employs human induced pluripotent stem cell-derived neurons (hiPSCNs) in a 96 well format.

222 ociated vs control human-induced pluripotent stem cell-derived neurons and 1199 genes that are altere

223 vated following infection of human embryonic stem cell-derived neurons and that this activation of JN

224 Similarly, induced pluripotent stem cell-derived neurons from a patient carrying a null

225 hippocampal neurons and induced pluripotent stem cell-derived neurons from a patient carrying a null

226 ng pathophysiology using induced pluripotent stem cell-derived neurons from AS patients and unaffecte

227 kin or SLP-2, as well as induced pluripotent stem cell-derived neurons from Parkin mutation carriers,

228 n the frontal cortex and induced pluripotent stem cell-derived neurons from subjects with behavioral

229 l replacement therapy with human pluripotent stem cell-derived neurons has the potential to ameliorat

230 g the landscape of open chromatin regions in stem cell-derived neurons helps functional interpretatio

231 shed a myelin formation assay with embryonic stem cell-derived neurons in microfluidic devices.

232 udy using embryonic stem cells and embryonic stem cell-derived neurons indicated that Nf1 RasGAP acti

233 vo and in cultured human induced pluripotent stem cell-derived neurons protects against mitochondrial

234 Induced pluripotent stem cell-derived neurons recapitulate developmental tau

235 s also apparent in human induced pluripotent stem cell-derived neurons, a disease-relevant cell type.

236 otective effect in human induced pluripotent stem cell-derived neurons, protecting up to 80% of neuro

237 ngs were corroborated in induced pluripotent stem cell-derived neurons, providing validation in a per

238 xpression profiling of human neuroepithelial stem cell-derived neurons, stimulated with normal consum

239 n growth cones with deficient actin veils in stem cell-derived neurons.

240 ex in GFP-LC3-transfected hippocampal neural stem cell-derived neurons.

241 ic tuning of intrinsic excitability in human stem cell-derived neurons.

242 ns and in isogenic human induced pluripotent stem cell-derived neurons.

243 including in mouse primary neurons and human stem cell-derived neurons.

244 an cells, including aged induced pluripotent stem-cell-derived neurons from patients with C9orf72-rel

245 The need to trial this approach with stem-cell-derived neurons is approaching, but it should

246 rs in the chloride reversal potential, human stem-cell-derived neurons represent a valuable tool for

247 embryonic stem (ES) and induced pluripotent stem cell-derived neuroprogenitors (NPs) develop primary

248 everage a combination of induced pluripotent stem cell-derived NF1 patient neural progenitor cells an

249 entiation systems; human induced pluripotent stem cell-derived nociceptors and TRKB-dependant SH-SY5Y

250 of multiple HuNoV strains in enterocytes in stem cell-derived, nontransformed human intestinal enter

251 Using human embryonic stem cell-derived NPCs to model neurogenesis, we found t

252 mall molecules on mouse pluripotent epiblast stem-cell-derived oligodendrocyte progenitor cells.

253 ion, we will discuss the safety of engrafted stem cell-derived OPCs, as well as approaches by which t

254 ways and inhibits cellular proliferation and stem-cell-derived organoid formation.

255 Stem cell-derived organoids and other 3D microtissues of

256 by AAV, such as nonhuman primates and human stem cell-derived organoids.

257 ron and astrocyte cytoplasm of TREX1 mutated stem cell-derived organoids.

258 ial (RG) cells in both primary tissue and in stem cell-derived organoids.

259 n bone formation, carried out by mesenchymal stem cell-derived osteoblasts, and bone resorption, carr

260 the rejection of xenogeneic human embryonic-stem-cell-derived pancreatic endoderm (hESC-PE) in mice.

261 been optimized to the extent that utilizing stem cell-derived platelets for cellular therapy is feas

262 Stem cell-derived platelets have the potential to replac

263 These results reveal that stem cell-derived PNS neurons are able to form functiona

264 xacerbated cell death in induced pluripotent stem cell-derived primary human neurons under oxidative

265 scRNA-seq covering distinct human embryonic stem cell-derived progenitor states.

266 d immunodeficiency (SCID), human pluripotent stem cell-derived (PSC-derived) neural progenitors migra

267 ontaining microparticles, nanoparticles, and stem cell-derived RBC products, with emphasis on improve

268 For example, stem cell-derived red blood cells (RBCs) are a potential

269 application of personalized approaches using stem-cell derived replacement beta cells.

270 The advent of stem cell-derived retinal organoids has brought forth un

271 as a resource for molecular staging of human stem-cell-derived retinal organoids.

272 ormed an extensive characterization of these stem cell-derived RGCs by examining the gene and protein

273 how that the same pathway is active in human stem cell-derived RGCs.

274 ansfection can be applied to human embryonic stem cell-derived RPE cells and that the method is safe,

275 y trials reported in The Lancet of embryonic-stem-cell-derived RPE cell transplants indicate no serio

276 e therapeutic potential of human-pluripotent-stem-cell-derived RPE.

277 We recently demonstrated that the neural stem cell-derived scar component has several beneficial

278 ell differentiated, while hair follicle (HF) stem cell-derived SCCs frequently exhibit EMT, efficient

279 onditions by which human induced pluripotent stem cell-derived sensory neurons can be cultured with r

280 n either rodent or human induced pluripotent stem cell-derived sensory neurons in vitro potently inhi

281 uregulin-1 (TIIINRG1) in induced pluripotent stem cell-derived sensory neurons strongly enhances myel

282 co-cultures using human induced pluripotent stem cell-derived sensory neurons thus provide insights

283 embryonic stem cell and induced pluripotent stem cell-derived single-cell gene expression profiles r

284 ic key processes may help to generate mature stem cell-derived somatic cells for therapeutic applicat

285 developed novel methods to co-culture neural stem cell-derived spiral ganglion-like neurons (ScNs) an

286 ith dynamic cell movement in mouse embryonic stem cell-derived sprouting assays.

287 These results suggest that stem cell-derived terminal cell types can provide an alt

288 It is now possible to deliver safely stem cell-derived, terminally differentiated, biological

289 ding amyloid-beta plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system.

290 rom diverse tissues by combining pluripotent stem cell-derived tissue-specific progenitors or relevan

291 cuses on the state of the art of a number of stem cell-derived tissues and details their application

292 Currently, stem cell-derived tissues are primarily "generic" geneti

293 Stem cell-derived tissues can be made in high purity, qu

294 nd pumping function in the diseased heart or stem cell-derived tissues.

295 Stem cell-derived transplants can be delivered to precis

296 invasive growth pattern of orthotopic cancer stem cell-derived tumors with low density of AC133(+) ce

297 In vitro analyses of mesenchymal stem cell-derived vascular smooth muscle cells (VSMCs) a

298 Well-characterized human pluripotent stem-cell-derived ventricular cardiomyocytes are strateg

299 expression signature broadly distinguishing stem cell-derived versus progenitor cell-derived AML, in

300 rast, clearly delineating subcutaneous tumor stem cell-derived xenografts from surrounding tissues.